Tonya N. Taylor, Ph.D.
Affiliations: | University of Oxford, Oxford, United Kingdom |
Google:
"Tonya Taylor"Mean distance: 17.57 (cluster 32) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wobst HJ, Denk F, Oliver PL, et al. (2017) Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy. Scientific Reports. 7: 43198 |
| Alter SP, Stout KA, Lohr KM, et al. (2015) Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration. Experimental Neurology |
| Taylor TN, Potgieter D, Anwar S, et al. (2014) Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse. Neurobiology of Disease. 62: 193-207 |
| Taylor TN, Alter SP, Wang M, et al. (2014) Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus. Neuropharmacology. 76: 97-105 |
| Janezic S, Threlfell S, Dodson PD, et al. (2013) Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proceedings of the National Academy of Sciences of the United States of America. 110: E4016-25 |
| Alter SP, Taylor TN, Sullivan P, et al. (2013) Progressive Noradrenergic Degeneration in Mice with Reduced Expression of the Vesicular Monoamine Transporter (VMAT2) Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 125 |
| Taylor TN, Caudle WM, Miller GW. (2011) VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease. Parkinson's Disease. 2011: 124165 |
| Taylor TN, Greene JG, Miller GW. (2010) Behavioral phenotyping of mouse models of Parkinson's disease. Behavioural Brain Research. 211: 1-10 |
| Taylor TN, Caudle WM, Shepherd KR, et al. (2009) Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 8103-13 |
| Guillot TS, Richardson JR, Wang MZ, et al. (2008) PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides. 42: 423-34 |